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Summary.-The August and Hooded rat strains are compatible at the major histo-
compatibility locus (both are AgB5 or Rtlc). Antisera against the minor histocom-
patibility antigens of Hooded rats were raised by immunizing August rats with
grafts of tumours or normal tissue. Such antisera, if transferred to normal un-
immunized August rats, cause them to reject i.v. administered Hooded rat leukaemia
(HRL) cells within a few hours, and X-irradiated August rats, for whom a graft of
HRL is lethal, can survive indefinitely if pretreated with the antiserum. The distribu-
tion of 1251-labelled HRL cells in the tissues of August rats was followed at times after
their injection, and it was found that, in the presence of antiserum, i.v. administered
leukaemic cells are rapidly destroyed in the liver and spleen. The active component
of the antiserum is IgG antibody, and its action is independent of the lytic elements of
complement. Antibody-mediated splenic and hepatic clearance of the leukaemia
cells is unaffected by total-body X-irradiation but reduced by treating the rats with
colloidal carbon. The data are consistent with the hypothesis that the rejection of
HRL across the histocompatibility barrier studied is, in the presence of antibody,
effected by immunophagocytosis.
THE ROLE of humoral antibody in the
rejection of neoplastic tissue has been at
issue for many years. The results of early
experiments (see reviews by Gorer, 1961
and M6ller, 1963) established that tumour
cells were susceptible to the cytolytic
action of antibodies and complement in
vitro and that passively administered
cytotoxic antisera would eliminate homo-
grafts of leukaemia cells, though not
usually solid tumour grafts, in vivo. In
most of these experiments, however,
demonstrably cytotoxic antisera could be
raised only by immunizing strains of
animals with different major histocom-
patibility (MHC) antigens from those of
the donor of the tumour graft; antisera to
non-MHC histocompatibility antigens
were not usually cytotoxic in vitro, and
the passive transfer of such antisera
frequently enhanced the growth of leu-
kaemia and solid-tumour grafts (Moller,
1963) rather than their rejection.
In our studies on the immune responses
between the MHC-compatible August and
Lister Hooded rat strains, we have found
that antisera raised in August rats against
theminorhisto-incompatibilities ofHooded
rats may have weak or non-existent
complement-mediated cytotoxicity to
Hooded rat leukaemia (HRL) cells in
vitro, and yet effect rapid rejection of the
grafted leukaemia cells on passive transfer
of the serum in vivo. In this paper we
demonstrate that August anti-Hooded
serum mediates the rapid removal of
grafted leukaemia cells from the circula-
tion by their destruction in the spleen and
liver. Antibody has been implicated in the
control of haematogenous spread of syn-
geneic and autochthonous tumours (Alex-
ander & Hall, 1970) and we suggest thatANTIBODIES TO NON-AgB ANTIGENS IN LEUKAEMIA REJECTION
the manner in which antibody mediates
the elimination ofHRL in August rats may
represent the principal mechanism by
which the host can remove cells bearing
weak histo-incompatibilities from the cir-
culation.
MATERIALS ANI) METHOI)S
Rats.-Pure-line Lister Hooded Cbi and
August (both AgB5 or Rtl C) rats were bred
at our own laboratories, and used when aged
between 10 weeks and 6 months; their weight
range was 150-250 g. Compatibility of the
August and Hooded strains at the MHC was
confirmed by the use of our own antisera
raised in other rat strains, and by commer-
cially available anti-AgB5 alloantiserum
(Searle Diagnostic, High Wycombe). We were
unable to induce mixed lymphocyte responses
(MLR) in cultures containing mixtures of
August and Hooded rat lymphocytes, a result
which is consistent with the report of Cramer
et al. (1974) that the August and Hooded rat
strains have identical MLR phenotypes.
The Hooded rat leukaemia (HRL). HRL
is a spontaneously arising acute T-cell leu-
kaemia which is extremely pathogenic in the
syngeneic male host (Wrathmell, 1976) where
it grows from as few as 10 cells. It has been
maintained by passage from a stock of frozen
cells laid down after the 20th passage. In most
cases HRL cells were obtained by cardiac
puncture from leukaemic Hooded rats with a
peripheral count in excess of 2 x 105 cells/ml
and separated from red blood cells on a
gradient of Lymphoprep (Pharmacia).
Production of August anti-Hooded (AUG
anti-HO) serum. AUG anti-HO serum could
be raised by immunizing with Hooded rat
skin, spleen, sarcoma or leukaemia cells but
not Hooded rat RBC. August rats were given
a minimum of 3 immunizations at 2-week
intervals with Hooded rat tumour tissue or
spleen cells and bled 7 days after the final
immunizatioin. The first immunization con-
sisted of 5 x 107 Hooded cells distributed i.p.
and s.c.; at subsequent immunizations l08
cells wA ere given. At least one ofthe immuniza-
tions with leukaemia or spleen cells was given
i.v., but sarcoma cells were always given i.p.
and s.c. Antisera raised against Hooded rat
skin were obtained by bleeding August rats
the day after their complete rejection of a
second graft of full-thickness Hooded skin.
Effective AUG anti-HO serum could be
raised by immunizing males or females with
tissue from either sex.
1251I-labelling of HRL cells. HRL cells
after separation from RBCs were w%ashed
twice and incubated at 107 cells/ml for 1-5 h
at 37°C in RPMI containing 10% foetal bovine
serum (FBS) and 0-2 ,uCi/ml of 1251-iodode-
oxyuridine (Radiochemical Centre, Amer-
sham). The cells were then washed x 3 in
serum-free medium and resuspended in
serum-free medium for injection. Labelled
HRL cells (5 x 107) were injected i.v. into
August rats, and the residual radioactivity
was measured at various times afterwards by
removing the tissues for counting in a gamma
scintillation counter. 5107 HRL cells gave
30,000-80,000 ct/min after labelling with
125TUdR.
Heat-killing of cells. HRL cells were incu-
bated at 56°C for 30 min.
X-irradiation of rats. 4-5 Gy w%hole-body
irradiation was delivered by a Marconi X-ray
machine at 220 kV with no filtration at a dose
rate of0-8 Gy/min.
Purification of cobra venom factor (CVF).-
CVF was purified from Naja naja venom
(Sigma Chemical Co. Ltd) by the methods
described by Lachmann etal. (1976). Phospho-
lipase A was inactivated with p-bromo-
phenacyl bromide. Sixty-five ,ul of the puri-
fied factor per rat was sufficient to decomple-
ment the rats for 24 h. Decomplementation
w%vas assessed by the inability ofthe recipients'
serum to induce lysis of sheep red blood cells
(SRBC) presensitized with rat anti-sheep
serum.
Affinity fractionation of A UG anti-HO
serum. Three fractions were prepared from
the whole antiserum: total immunoglobulin,
"IgM-rich" and IgG only. Specifically purified
rabbit anti-rat F(ab')2 or sheep anti-rat IgM
wvere covalently linked to activated CNBr
Sepharose 4BR (Pharmacia, Gt Britain Ltd)
and 4 ml AUG anti-HO serum was then ad-
sorbed on to either conjugate. The unbound
materials were eluted with lM NaCl in phos-
phatebufferandspecificallyadsorbed material
was eluted with 3M KSCN and dialysed
against PBS. An IgG preparation from AUG
anti-HO serum was obtained by applying the
5000 (NH4)2SO4 precipitable material to
DEAE cellulose. The precipitate was dis-
solved in 17-5 mm phosphate buffer and eluted
from the DEAE in the same buffer. The IgG-
containing fractions were then adsorbed on
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to Sepharose-linked anti-rat F(ab')2 and the
unbound material discarded. The fractions
were concentrated to the original antiserum
volume by ultrafiltration (PM1O diaflo ultra
filter, Amicon, Massachusetts). Individual
immunoglobulins in the fractions were meas-
ured by the ability of the flactions to inhibit
the agglutination of glutaraldehyde-fixed
SRBC coated with purified rat immuno-
globulin-s in the presence of anti-rat-immuno-
globulin antibodies. The IgG preparation
from AUG anti-HO serum had virtually no
IgM, IgA or IgE activities, as determined by
passive haemagglutination inhibition.
RESULTS
Protection of X-irradiated August rats
against the growth of HRL cells by AUG
anti-HO serumn
Normal August rats rejected large
numbers of HRL cells at the first immun-
ization. If August rats were given total-
body irradiation with 4-5 Gy X-rays, how-
ever, an inoculum of as few as 104 HRL
cells would grow to kill the recipients
within 3 weeks. X-irradiated August rats
could be protected against a potentially
lethal dose of HRL by pretreatment with
AUG anti-HO serum. Table I shows the
results of 3 experiments in which X-
irradiated August rats were protected
against death from leukaemia with anti-
serum.
TABLEI. ProtectionofX-irradiatedAugust
rats against the growth of HRL by A UG
anti-HO serum
Serum ip.).
AUG anti-HO spleen
,, HRL cells
,, HO skin
Normal AUG
N\one
(ml)
(2-5)
(2e5)
(3-0)
(25-3.0)
No. rats
dying of
leukaemia
0/5 (62)t
0/5 (42)t
0/6 (42)t
12/12 (14)*
12/12 (15)*
t Day of termination of experiment.
* Mean survival time in days.
Sera were injected 4 hI before 106 HRL, cells giVenl
i.\. and 24 li after wNhole-body X-irracliation of
4-5 Gy.
Elimination of HRL cells front August rGat
spleens with AUG anti-HO serum
HRL cells, given i.v. to normal August
rats, grew preferentially in the spleen
until they were eliminated, some 7 days
later, as the result of a primary immune
response. The presence of live HiRL cells
in an August rat spleen could be detected
by transfer of the whole spleen to a
Hooded rat; as few as 1O HRL cells were
known to be lethal in a syngeneic recipient.
Table II illustrates the effects of prior
transfer ofAUG anti-HO serum to normal
August rats on the rate of elimination of
HRL cells, as judged by "spleen transfer"
tests. In the presence of antiserum live
HRL cells disappeared from the spleens
ofAugust rats within 24 h.
TABLE II. Elimination of HRL cellsfroml
August rat spleens assayed by "spleen
transfer"
Serum
(2-5 ml)
D)ay of August
spleen
transfer to
Hooded rat
1-7
9-10
NAS§ i.p. 1
AUG-anti-HO i.p. I
AUG-anti-SRBC 1
106 HRL cells given i.xv. tlhe (lay
ministration of serum.
* Mean survival in days.
t Day of termination of experiment.
§ Normal Auiguist serutim.
Hoocle(d rats
(lea(l with
HRL
8/8 (21)*
0/2 (60)t
8/8 (29)*
0/11 (60)t
4/4 (31)*
following acl-
Elimination of 1251-labelled HRL cells
from liver and spleen
Fig. I shows the effects of pretreating
normal August rats with either AUG
anti-HO serum or normal August serum
on the rate of elimination of 1251-labelled
HRL cells in the first 20 h after their i.v.
injection. In the first hour, 1251 activity
increased in the livers and spleens of rats
in both antiserum-treated and untreated
groups, as labelled HRL cells left the lungs.
Between 1 and 6 h, however, 1251 activity
was lost very rapidly from the livers and
the spleens of antiserum-treated rats, and
by 20 h represented only 1-2% of the
41()
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A
Ib
"ll
hours after injection
FIa. 1. The effect of AUG anti-HO serum
on the distribution of 1251 (expressed as
% injected) in the organs of August rats at
times after receiving 5 x 107 125I-HRL i.v.
Each point represents the mean of 3-4
recipients and the bars represent the
avrerage deviation from the mean. 0-5 ml
AUG anti-HO serum or normal August
serum were given i.p. 4 h before the i.v.
1251-HRL. 1251 activities for blood repre-
sent total blood volume. (A) 125I in lung
(*) and liver (0) of rats pretreated with
0-5ml AUG anti-HO serum. Values in lung
(LOi) and liver (0) of rats pretreated with
normal August serum. (B) 1251 in spleen
(-) and blood (*) of rats treated with
AUG anti-HO serum; in spleen (A) and
blood (C)) of rats treated with normal
August serum.
activity found in the same tissues of
control rats.
1251 activity in the cell-free plasma of
rats treated with antiserum rose to a
maximum of 70% of the total blood acti-
vity at 3 and 6 h; in the control rats, less
than 20% of the blood activity was in the
cell-free plasma at 5 min and 3 h but this
increased to ' 50% after 3 h.
The volumes of antiserum required per
rat to demonstrate accelerated elimination
of 1251-HRL in liver and spleen were far
smaller than those needed to protect X-
irradiated August rats against death from
leukaemia; differential loss of 1251 was
detectable at 0 1-0-2 ml AUG anti-HO
serum per rat, whereas 2-5-3-0 ml of
antiserum was the minimum volume
needed to ensure the survival of X-
irradiated rats given HRL cells (data in
Table I).
,5 Some 80% of the total 1251 activity
injected at 0 h was eliminated within 20 h
by August rats pretreated with normal
-L; August serum and by untreated August
rats (data not shown). A similar rate of
non-immunological elimination was re-
ported for 1251-labelled HRL cells in
syngeneic (Hooded) rats (Sadler & Alexan-
der, 1976) and probably represents the
clearance of mechanically and/or radio-
..; logically damaged cells. To confirm that
the accelerated disappearance of 1251 from
the liver and spleen ofrats pretreated with
AUG anti-HO serum reflected the removal
of viable HRL cells from the circulation,
75
0 10
0
I
\J
9-',
J.t.s =i s-3
hours after injection
FIG. 2. The distribution of 125I at times
after the injection of heat-killed 125I-HRL
in the organs of August rats. AUG anti-HO
serum or normal August serum given 4 h
before 5 x 107 killed HRL cells i.v. Points
represent mean values from 3 animals and
bars represent the ranges. 1251 in liver (*),
spleen (A) and lung (-) of rats receiving
0-5 ml AUG anti-HO serum i.p.; 1251 in
liver (0), spleen (A) and lung (EOi) of rats
receiving 0-5 ml normal August serum.
' 2 A 11 7: {)
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heat-killed I251-labelled HRL cells were
given to August rats in the presence or
absence of antiserum. Fig. 2 shows 1251
activities recovered from lung, spleen and
liver at times after the injection of killed
labelled cells. Immediately after injection
(i.e. at 5 min) most of the injected 1251
activity was recovered from the lungs of
rats treated with antiserum or normal
August serum, but by 1 h the mean acti-
vity recovered from the lungs had fallen
to l1* and 1*2500 respectively, without
compensatory increases in 1251 activity
in liver and spleen. 1251 activitiesrecovered
from the thyroid and blood plasma ofboth
groups of rats at 1 h were negligible,
indicating that the bulk of 125J from killed
HRL cells had been excreted within the
first hour after their injection. As Fig. 2
shows, the uptake and loss of 1251 in liver
and spleen following injection of dead
HRL cells were identical in rats treated
with AUG anti-HO serum and in those
given normal serum.
Characterization of the effective antibody
The immunoglobulin fractions prepared
from whole AUG anti-HO serum were
tested for their ability to increase the rate
of disappearance of 1251-HRL in August
rats as compared with the effects ofnormal
serum. 1251 activities in the livers and
spleens were counted 20 h after the injec-
tion of 1251-HRL cells into rats pretreated
with the fractions under test or control
sera. The amount offractionated immuno-
globulin given per rat was made roughly
equivalent to the amount fouind in 0 5 ml
of the whole antiserum. Table III shows
the results of these experiments. It is
clear that the effects of the "IgM-rich"
preparation were not significantly different
from the effects of normal August serum,
whereas the IgG preparation was as
effective as the whole antiserum.
Attempts to demonstrate specificity of
AUG anti-HO sera for Hooded rat cells
were limited by the cross-reactivity of
minor histocompatibility antigens between
our rat strains. The activity of AUG anti-
HO serum on HRL cells in vivo was, how-
ever, abolished by prior absorption of the
antiserum with Hooded rat cells, but not
by absorption with August rat cells.
August rat antisera raised against un-
related cells, such as SRBC, did not ac-
celerate the clearance rate of 125I-HRL in
August rats.
Inmntnophagocytosis in the antibody-
mediated rejection ofHRL cells
The results of 51Cr release from labelled
HRlL cells in vitro indicated that most of
the AUG anti-HO sera used by us had
negligible C'-dependent lytic activity. The
highest lytic titres (e.g. 500o specific lysis
at 1/5 dilution of the antiserum with
rabbit serum as C' source) were obtained
with antisera raised against HRL cells; no
specific lysis was detectable with antisera
raised against Hooded rat skin or sarcoma.
Demonstration that the haemolytic com-
ponents of complement were not required
for the in vivo destruction of 125I-HRL
TABLE III.-The effect8 of AUG anti-HO sermm fractions on the elirtination of 125I-HRL
in vivo
Serum/fractioii teste(l
(0 5 ml)
Normal AUG
AUG anti-HO WS
Ig
"Tg-M-rich'
TgG
Ig content of fraction*
TgG IgM\l
(mg) ((Lg)
NI) ND
3-:3 125
4-4 168
0-015 153
3-:1 _
O 1251 activity recovered
at 2014t
Liver Spleen
8-1 + 0-8
0-1 +0-1
0-2+0-1
6-7+0-2
0-8+0-2
8-4 + 1*3
02 +0.1
0-04 + 0-03
7-6+0-9
0-2+0-04
* Amounts Igs/aliquot of fraction/rat,; XWS: whliole, anitiserum; Ig, IgAl anid IgG: fractions prepared as
(lescribed in text. Mean data of 4-6 rat,s+s.d.
Fractiorns or whole sera given i.p. 4 h before 5 x 107 1251-HRL cells iv..
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cells by antibody is provided by the experi-
mental results shown in Table IV. In
August rats that were given active CVF,
decomplementation was complete 0 5 h
after the receipt of CVF, and remained
complete until the animals were killed
for 125J counting at 20 h.
The rate of elimination of 12514HRL
cells in the presence ofAUG anti-HO anti-
body was unaffected by total-body X-
irradiation oftherecipientratswith 45Gy,
which corroborated the results of the pas-
sive protection experiments (Table I).
Since the X-irradiation could be per-
formed from 4 days to 4 h before injection
of 1251-HRI, and yet have no effect, it
seemed likely that macrophages resident in
spleen and liver, rather than cells freshly
recruited from the circulation, were the
agentswherebyantibody-coatedleukaemia
cells were destroyed. To test this hypo-
thesis, therefore, groups of rats were
treated with colloidal carbon in an attempt
to blockade the reticulo-endothelial sys-
tem before injection of 1251-HRL cells.
Fig. 3 shows the effects of prior injection
of 0 5 ml colloidal carbon on the rate of
loss of 1251 activity from the liver of rats
50
40
0
- 30
VT
- 20
L1 / -.-
- -
* ~~~~~~~~~~~~~1~ T~~~~
1 2 3 4 5 6
hours af ter inject ion
FIG. 3. The effect of treatment with col-
loidal carbon on the rate of loss of 1251
from the lixvor after the injection of 5 x 107
1251-HRL cells. Rats pretreated witli
serum 4 h before receiving the HRL, and
0-5 ml colloidal carbon (Pelikan ink) giv7en
iv. 20-30 min before HRL cells. Points
represent means from 3-6 rats and the bars
indicate the average variation from the
mean. 125f in the liver of rats treated with
0-5 ml AUG anti-HO serum alone (0) or
antiserum + carbon (f*); 1251 in the liver of
rats treated itih 0-5ml normal August
serum alone (0) or niormal serum+
carbon (n)-
TABLE IV. Effect of cobra venom factor
(CVF) on the in vivo cytotoxicity of
AUG anti-HO serum to HRL cells in
August rats
0 1251 recovered at 20 h
Serum ,
(0-5 ml i.p.) CVF Liver Spleen
AUG anti-HO
NAS
NAS
- 0-2+0-05
+ 0-2+0-04
* 0-2+0-05
- 10-7 + 0-6
+ 11-1+0-8
0-03 + 0-05
0-01 + 0-01
0-02 + 0-03
7-6 + 0-9
9-3+0-2
* CVF inactivated at 70°C for 30 min.
NAS: normal August serum.
65 ,ul CVF given i.p. at the same time as the anti-
serum, 5 x 107 1251-HRL cells 4 It after the anti-
serum. Figures represent means + average deviation
based on 3-6 rats.
injected with 1251-HRL cells. Carbon
retarded the rate of disappearance of
1251 from the livers of antiserum-treated
rats, and its effects appeared to be most
marked during the first 2-3 h after its
injection; thereafter the rates at which
1251 activity disappeared from the livers
of antiserum-treated rats were similar in
carbon-treated and untreated rats. The
non-immunological removal of 1251-HRL
cells (as represented by 1251 activities in
the livers of animals treated with normal
serum) appeared to be only slightly re-
tarded by carbon, which probably reflects
the far slower rate ofremoval ofmoribund
cells by macrophages than the rate of
phagocytosis of cells opsonized with anti-
body. The effect ofcarbon on the antibody-
mediated clearance of 125I-HRL cells in
the spleen was less apparent than its
effect on liver clearance. Slight retardation
ofthe loss of 125J in the spleen was detect-
able 2 h after the injection of 1251-HRL
cells, but at 3 h residual activities in the
spleens of carbon-treated animals were
similar to those in the spleens of rats
treated with antiserum alone. The failure
of carbon to produce a more marked effect
on the rate of splenic clearance of HRL
cells may be the result of a faster rate of
elimination of carbon by the spleen than
by liver.
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DISCUSSION
The passive transfer of AUG anti-HO
serum to August rats accelerated the rejec-
tion of HRL cells and, in immuno-
suppressed August rats, prevented the
lethal growth of the leukaemia. The
mechanism by which antibody effects
rapid rejection of HRL cells does not
involve complement-mediated lysis but
does involve radio-resistant cellular ele-
ments in the liver and spleen. The X-
irradiation resistance of antibody killing
of HRL cells makes it unlikely that mono-
cytes and polymorphonuclear leucocytes
recruited from the circulation, or non-
circulating K cells, co-operate with anti-
body. Resident macrophages in the spleen
and liver are reported to be very radio-
resistant (Anderson & Warner, 1976) and
our results suggest that it is these cells
which clear opsonized leukaemia cells from
the circulation by immunophagocytosis.
Shin et at. (1974) have also reported that
alloantibody can suppress lymphoma
growth in mice by co-operation with host
cells. In these authors' experiments, how-
ever, antibody could not mediate tumour
suppression in sublethally X-irradiated
mice, but the response could be restored
by a variety ofcell types from unirradiated
mice: macrophages, lymphocytes, poly-
morphonuclear leucocytes and platelets
all restored the capacity of the host to
suppress lymphoma growth in the presence
of antibody. To add to a confused picture,
frozen-and-thawed macrophages also
mediated the suppression of lymphoma
growth, and the authors concluded that
the mechanism did not involve immuno-
phagocytosis. It is possible that the pat-
tern of effector mechanisms generated
between the rat strains used by us differs
from that between the mouse strains used
by Shin and his co-workers.
The MHC-compatible August and
Hooded rat strains differ at the Pta locus
(Howard & Scott, 1974) which determines
differentiation antigens on mature T cells,
and at other minor histocompatibility loci.
The antibodies which mediate the rejection
ofHRL are not directed solely against Pta
antigens, since effective antisera can be
raised by immunizing with Hooded rat
sarcoma or skin, and it has been cate-
gorically stated (Butcher & Howard, 1977)
that anti-Pta antibodies are not raised by
skin grafting. The tissue distribution of
the antigens to which the various August
anti-Ho sera are directed has been
investigated by an anti-globulin binding
assay; the results from this will be dis-
cussed in a further publication (Hooton
et al., in preparation). In their studies on
the antibody responses to histocompati-
bility antigens in rats, Miller & De Witt
(1974) found that IgM antibodies were not
formed to minor histocompatibilities and
that these antigens preferentially evoked
the production of non-complement-fixing
IgG. In our experiments we also have
found that the effective antibody against a
graft bearing non-MHC histocompatibility
differences is IgG, not IgM, and that its
action in vivo is independent of comple-
ment-mediated lysis.
The results of past studies have shown
that, in general, antisera which are not
cytolytic to tumour cells in vitro are not
able to confer protection against the same
cells in vivo, and it has been a common
experience that antisera directed against
histocompatibility antigens which are not
part ofthe MHC do not usually have anti-
tumour activity either in vivo or in vitro
(M6ller, 1963). Our August anti-HO sera
were not strongly cytolytic in vitro but
were extremely effective against HRL cells
in vivo. The effective action of antibody
against HRL cells may have been related
to the physical nature ofthe graft and the
manner in which it was introduced to the
hostin our experiments. One might predict
that an i.v. single-cell suspension would be
more accessible to the action of antibody
than a peripheral graft of solid tissue, and
we are currently investigating the effects
of August HO sera on the growth of
Hooded rat sarcomas.
The elimination of circulating tumour
cells in the liver and spleen via the action
of antibody is particularly relevant to the
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mechanism by which the vascular spread
of syngeneic or autochthonous tumours
may be controlled bytheimmuneresponse.
Citations of positive anti-tumour activity
in vivo by antibodies to tumour-associated
antigens are few, but in one study from
our laboratory (Proctor et al., 1973) an
immunologically specific factor in the
lymph and blood of rats with syngeneic
sarcomas was found to prevent the de-
velopment of lung metastases. Although
the factor was not positively identified as
antibody, it was shown to be humoral in
nature and unassociated with sensitized
mononuclear cells.
This work was supported by grants from the
Medical Research Council, the Cancer Research
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